In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, includ...

GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK) has a valuation score of 80/100 (strong), profitability score of 82/100 (strong), financial health score of 61/100 (moderate), Piotroski F-Score of 6/9, Altman Z-Score of 2.51 (grey zone), revenue growth of +3.7% YoY.

Neutral

Analyst Consensus

Hold

Wall Street consensus estimates — not a PMP forecast · Updated Sep 1, 2026

Analyst Recommendations32 analysts · 2026-08-01
6
8
15
3
Strong Buy 6Buy 8Hold 15Sell 3Strong Sell 0
GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK) Valuation & P/E History →GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK) Financial Statements →
Share:

Explore More Stocks

AAPLMSFTNVDAGOOGLAMZNMETATSLAJPMWMTVView all stocks →